Adipo Therapeutics completes $1.9M seed funding bridge to advance obesity and Type 2 diabetes treatment
Adipo Therapeutics completes $1.9M seed funding bridge to advance obesity and Type 2 diabetes treatment
01/31/24, 4:17 PM
Location
indianapolisMoney raised
$1.9 million
Industry
biopharma
therapeutics
health care
biotechnology
Round Type
seed
Investors
Vision Tech Partners, Iu Ventures, Elevate Ventures, Purdue Research Foundation
Adipo Therapeutics has successfully completed a $1.9 million seed funding bridge to advance obesity and Type 2 diabetes treatment. The company will embark on raising $35M Series A financing.
Company Info
Location
1210 waterway blvd.
indianapolis, indiana, united states
Additional Info
Adipo Therapeutics, an Indiana biotechnology company, is developing polymer-based, Notch-inhibiting nanoparticles that are injected directly into adipose (fat) tissue to induce browning, or white-to-beige adipocyte transformation.